News | March 18, 2023
Eiko LifeSciences to acquire 5% stake in Vivacious Pharmatex
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
ELL will be the preferred source of supply for some the key Raw Materials to VPPL at "Arm's Length" transaction.
“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Subscribe To Our Newsletter & Stay Updated
